Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Sanai Health Industry Group Co's PB Ratio or its related term are showing as below:
FRA:WUP0'
s PB Ratio Range Over the Past 10 Years
Min: 0.07 Med: 0.97 Max: 15.11
Current: 0.09
During the past 13 years, Sanai Health Industry Group Co's highest PB Ratio was 15.11. The lowest was 0.07. And the median was 0.97.
FRA:WUP0's PB Ratio is ranked better than 99.24% of 921
companies
in the Drug Manufacturers industry
Industry Median: 1.9
vs FRA:WUP0: 0.09
During the past 12 months, Sanai Health Industry Group Co's average Book Value Per Share Growth Rate was -4.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -14.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sanai Health Industry Group Co was 90.60% per year. The lowest was -70.10% per year. And the median was 0.80% per year.
Back to Basics: PB Ratio
Sanai Health Industry Group Co (FRA:WUP0) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sanai Health Industry Group Co PB Ratio Related Terms
Sanai Health Industry Group Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sanai Health Industry Group Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanai Health Industry Group Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanai Health Industry Group Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sanai Health Industry Group Co's PB Ratio falls into.
Sanai Health Industry Group Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sanai Health Industry Group Co (FRA:WUP0) has a PB Ratio of 0.11 as of Jul. 14, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sanai Health Industry Group Co and its competitors. This is 89% below median its historical median of 0.97. Over the past decade, Sanai Health Industry Group Co's PB Ratio has ranged from 0.07 to 15.11. According to the industry distribution chart, Sanai Health Industry Group Co ranks #7 out of 921 companies in the Drug Manufacturers industry, placing it in the top 0.8%.
Is Sanai Health Industry Group Co's PB Ratio too high?
Sanai Health Industry Group Co's current PB Ratio of 0.11 is 89% below median its 10-year median of 0.97. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 15.11. The Drug Manufacturers industry median PB Ratio is 1.90. Sanai Health Industry Group Co's value of 0.11 is 94.2% below this industry median. Based on the distribution chart, Sanai Health Industry Group Co ranks #7 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanai Health Industry Group Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Sanai Health Industry Group Co's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sanai Health Industry Group Co ranks #7 out of 921 companies for PB Ratio. This places Sanai Health Industry Group Co in the top 1% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.90. Sanai Health Industry Group Co's value of 0.11 is 94.2% below this benchmark. Historically, Sanai Health Industry Group Co's own PB Ratio has ranged from 0.07 to 15.11 over the past decade. While the company's 10-year median is 0.97 vs. the industry median of 1.90, Sanai Health Industry Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.90, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanai Health Industry Group Co's current PB Ratio of 0.11 is 94.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sanai Health Industry Group Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanai Health Industry Group Co's current PB Ratio is 0.11, which is 89% below median its own 10-year median of 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanai Health Industry Group Co stock overvalued right now?
Sanai Health Industry Group Co (FRA:WUP0) has a current PB Ratio of 0.11. The stock's GF Value™ is €0.05, compared to a current price of €0.03 — trading 50% below its estimated fair value. The current PB Ratio is 0.11, which is 89% below median its 10-year median of 0.97 and 94.2% below the Drug Manufacturers industry median of 1.90. Sanai Health Industry Group Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sanai Health Industry Group Co (FRA:WUP0), the current PB Ratio is 0.11 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanai Health Industry Group Co (FRA:WUP0) Overvalued in 2026?
Based on GuruFocus' analysis, Sanai Health Industry Group Co stock appears to be undervalued.
The current stock price of €0.03 is trading 50% below its estimated GF Value™ of €0.05.
Key valuation signals for FRA:WUP0:
PB Ratio: 0.11 (89% below median its 10-year median of 0.97)
GF Value™: €0.05 vs. price of €0.03 (50% below fair value)
Industry Position: 94.2% below the Drug Manufacturers median (#7 of 921)
No single metric tells the full story. See the FRA:WUP0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanai Health Industry Group Co Business Description
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products include development, manufacturing, marketing, and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives the majority of its revenue from the PRC.
40GF Score
Get the complete analysis for FRA:WUP0
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:WUP0 has been successfully added to your 
